Dr. Arno Wilhelm appointed Director Growth & Client Solutions DACH at Inizio Engage

Inizio Engage is further strengthening its growth and client solutions strategy across Germany, Austria and Switzerland. Dr. Arno Wilhelm has been appointed Director Growth & Client Solutions DACH and will support pharmaceutical, biopharmaceutical and OTC companies with integrated commercialization, engagement and go-to-market solutions.

Inizio Engage, a global partner for Healthcare Engagement and Commercialization, has appointed Dr. Arno Wilhelm as Director Growth & Client Solutions DACH. In his new role, he will be responsible for business development and strategic client consulting across the DACH region.

The appointment reinforces Inizio Engage’s position as a partner for pharmaceutical companies, biopharmaceutical organizations, OTC manufacturers and healthcare organizations seeking to address complex market access processes, increasing competitive pressure and growing requirements for omnichannel engagement.

Why Inizio Engage is strengthening its Client Solutions capabilities in DACH

The healthcare and pharmaceutical market in the DACH region is changing significantly. Market access, launch excellence, medical engagement, sales, marketing and data-driven customer activation increasingly need to work together as part of one integrated approach.

For pharmaceutical and healthcare companies, this creates a growing need for integrated commercialization solutions that engage HCPs, patients, payers and other stakeholders through relevant channels.

Bettina Weinem, General Manager DACH at Inizio Engage, sees the appointment of Dr. Arno Wilhelm as an important step in the continued development of the DACH business:

“With Dr. Arno Wilhelm, we are gaining a proven expert who combines strategic depth with strong operational execution. I am very pleased to welcome him to the team.”

Connecting healthcare strategy with operational execution

Dr. Arno Wilhelm brings a strong scientific background and many years of experience in the healthcare industry. Following his studies in biology, he developed a broad strategic and operational profile across strategy development, go-to-market, medical solutions, marketing and sales.

In senior roles at renowned consulting and service providers in the industry, Wilhelm supported pharmaceutical companies and healthcare brands across key stages of commercialization. These include strategic positioning, market access, customer activation, and the design and implementation of integrated communications, marketing and sales solutions.

As Director Growth & Client Solutions DACH, Wilhelm will support clients in identifying growth opportunities, developing omnichannel strategies and implementing effective commercialization models for the DACH market.

Global healthcare engagement partner with local DACH expertise

Inizio Engage is a global partner for Healthcare Engagement and Commercialization. The company supports pharmaceutical, biopharmaceutical and OTC manufacturers in making better-informed decisions, engaging stakeholders more effectively and creating measurable impact in healthcare delivery.

With more than 6,000 experts across over 20 countries, Inizio Engage combines global scale, local market expertise and innovative thinking. Inizio Engage provides healthcare and life sciences clients with comprehensive support across the entire product lifecycle.